

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.53388040 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.53388040 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.25068966 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 7.25068966 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.62851268 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.09045556 |
| 7 | indole-containing compound catabolic process (GO:0042436) | 5.88763613 |
| 8 | indolalkylamine catabolic process (GO:0046218) | 5.88763613 |
| 9 | tryptophan catabolic process (GO:0006569) | 5.88763613 |
| 10 | bile acid biosynthetic process (GO:0006699) | 5.69887679 |
| 11 | kynurenine metabolic process (GO:0070189) | 5.67650987 |
| 12 | urea cycle (GO:0000050) | 5.60279036 |
| 13 | urea metabolic process (GO:0019627) | 5.60279036 |
| 14 | tryptophan metabolic process (GO:0006568) | 5.58165538 |
| 15 | glyoxylate metabolic process (GO:0046487) | 5.57849723 |
| 16 | negative regulation of fibrinolysis (GO:0051918) | 5.50145163 |
| 17 | high-density lipoprotein particle remodeling (GO:0034375) | 5.43612643 |
| 18 | regulation of fibrinolysis (GO:0051917) | 5.37776468 |
| 19 | sulfur amino acid catabolic process (GO:0000098) | 5.30680067 |
| 20 | epoxygenase P450 pathway (GO:0019373) | 5.29884530 |
| 21 | regulation of protein activation cascade (GO:2000257) | 5.28192146 |
| 22 | cysteine metabolic process (GO:0006534) | 5.25225801 |
| 23 | protein carboxylation (GO:0018214) | 5.24233543 |
| 24 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.24233543 |
| 25 | complement activation, alternative pathway (GO:0006957) | 5.23147138 |
| 26 | nitrogen cycle metabolic process (GO:0071941) | 5.15550601 |
| 27 | alpha-linolenic acid metabolic process (GO:0036109) | 5.05398926 |
| 28 | bile acid metabolic process (GO:0008206) | 4.97768535 |
| 29 | regulation of complement activation (GO:0030449) | 4.90775337 |
| 30 | serine family amino acid catabolic process (GO:0009071) | 4.87278413 |
| 31 | reverse cholesterol transport (GO:0043691) | 4.85804816 |
| 32 | aromatic amino acid family metabolic process (GO:0009072) | 4.85311800 |
| 33 | homocysteine metabolic process (GO:0050667) | 4.84345721 |
| 34 | L-serine metabolic process (GO:0006563) | 4.81924660 |
| 35 | regulation of triglyceride catabolic process (GO:0010896) | 4.81434795 |
| 36 | regulation of cholesterol esterification (GO:0010872) | 4.78630803 |
| 37 | protein-lipid complex remodeling (GO:0034368) | 4.77625143 |
| 38 | macromolecular complex remodeling (GO:0034367) | 4.77625143 |
| 39 | plasma lipoprotein particle remodeling (GO:0034369) | 4.77625143 |
| 40 | acylglycerol homeostasis (GO:0055090) | 4.72131524 |
| 41 | triglyceride homeostasis (GO:0070328) | 4.72131524 |
| 42 | tyrosine metabolic process (GO:0006570) | 4.63392680 |
| 43 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.59964155 |
| 44 | ethanol metabolic process (GO:0006067) | 4.55987966 |
| 45 | phospholipid efflux (GO:0033700) | 4.54104114 |
| 46 | exogenous drug catabolic process (GO:0042738) | 4.49968436 |
| 47 | alpha-amino acid catabolic process (GO:1901606) | 4.45404136 |
| 48 | coenzyme catabolic process (GO:0009109) | 4.42815210 |
| 49 | bile acid and bile salt transport (GO:0015721) | 4.40036414 |
| 50 | amino-acid betaine metabolic process (GO:0006577) | 4.31601883 |
| 51 | lysine catabolic process (GO:0006554) | 4.31521800 |
| 52 | lysine metabolic process (GO:0006553) | 4.31521800 |
| 53 | negative regulation of sterol transport (GO:0032372) | 4.28001337 |
| 54 | negative regulation of cholesterol transport (GO:0032375) | 4.28001337 |
| 55 | glycine metabolic process (GO:0006544) | 4.26679362 |
| 56 | indolalkylamine metabolic process (GO:0006586) | 4.24876441 |
| 57 | intestinal absorption (GO:0050892) | 4.24043668 |
| 58 | plasma lipoprotein particle clearance (GO:0034381) | 4.18492204 |
| 59 | cellular ketone body metabolic process (GO:0046950) | 4.15989568 |
| 60 | cellular amino acid catabolic process (GO:0009063) | 4.14981523 |
| 61 | cholesterol efflux (GO:0033344) | 4.13424074 |
| 62 | cellular biogenic amine catabolic process (GO:0042402) | 4.11105293 |
| 63 | amine catabolic process (GO:0009310) | 4.11105293 |
| 64 | cellular glucuronidation (GO:0052695) | 4.10604800 |
| 65 | cellular modified amino acid catabolic process (GO:0042219) | 4.09776804 |
| 66 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 4.09120947 |
| 67 | serine family amino acid metabolic process (GO:0009069) | 4.05530845 |
| 68 | imidazole-containing compound metabolic process (GO:0052803) | 4.05248044 |
| 69 | proline metabolic process (GO:0006560) | 4.04702474 |
| 70 | intestinal cholesterol absorption (GO:0030299) | 4.01908171 |
| 71 | plasma lipoprotein particle assembly (GO:0034377) | 3.99111522 |
| 72 | glutamate metabolic process (GO:0006536) | 3.97815329 |
| 73 | low-density lipoprotein particle remodeling (GO:0034374) | 3.92834657 |
| 74 | blood coagulation, intrinsic pathway (GO:0007597) | 3.90096532 |
| 75 | fibrinolysis (GO:0042730) | 3.89920749 |
| 76 | serine family amino acid biosynthetic process (GO:0009070) | 3.88921437 |
| 77 | benzene-containing compound metabolic process (GO:0042537) | 3.87925713 |
| 78 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.86380378 |
| 79 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.86380378 |
| 80 | arginine metabolic process (GO:0006525) | 3.83689160 |
| 81 | cofactor catabolic process (GO:0051187) | 3.82149979 |
| 82 | primary alcohol catabolic process (GO:0034310) | 3.82147956 |
| 83 | regulation of bile acid biosynthetic process (GO:0070857) | 3.81647397 |
| 84 | aldehyde catabolic process (GO:0046185) | 3.79368032 |
| 85 | omega-hydroxylase P450 pathway (GO:0097267) | 3.78248264 |
| 86 | cytolysis (GO:0019835) | 3.77585837 |
| 87 | protein-lipid complex subunit organization (GO:0071825) | 3.74424998 |
| 88 | regulation of cholesterol homeostasis (GO:2000188) | 3.72758657 |
| 89 | cholesterol homeostasis (GO:0042632) | 3.72232314 |
| 90 | drug metabolic process (GO:0017144) | 3.68425466 |
| 91 | complement activation, classical pathway (GO:0006958) | 3.68407982 |
| 92 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.67300980 |
| 93 | protein activation cascade (GO:0072376) | 3.67047381 |
| 94 | sterol homeostasis (GO:0055092) | 3.65980164 |
| 95 | ethanol oxidation (GO:0006069) | 3.65485164 |
| 96 | plasma lipoprotein particle organization (GO:0071827) | 3.65151294 |
| 97 | regulation of apoptotic cell clearance (GO:2000425) | 3.64250095 |
| 98 | phospholipid homeostasis (GO:0055091) | 3.64075325 |
| 99 | negative regulation of lipase activity (GO:0060192) | 3.64046526 |
| 100 | glucuronate metabolic process (GO:0019585) | 3.63804619 |
| 101 | uronic acid metabolic process (GO:0006063) | 3.63804619 |
| 102 | organic acid catabolic process (GO:0016054) | 3.63089627 |
| 103 | carboxylic acid catabolic process (GO:0046395) | 3.63089627 |
| 104 | acute-phase response (GO:0006953) | 3.61153264 |
| 105 | complement activation (GO:0006956) | 3.59110585 |
| 106 | ketone body metabolic process (GO:1902224) | 3.58629716 |
| 107 | drug catabolic process (GO:0042737) | 3.57025826 |
| 108 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.55690533 |
| 109 | regulation of plasminogen activation (GO:0010755) | 3.55246613 |
| 110 | lipoprotein metabolic process (GO:0042157) | 3.54518572 |
| 111 | positive regulation of lipid catabolic process (GO:0050996) | 3.53299618 |
| 112 | protein-lipid complex assembly (GO:0065005) | 3.52841376 |
| 113 | negative regulation of hemostasis (GO:1900047) | 3.50575889 |
| 114 | negative regulation of blood coagulation (GO:0030195) | 3.50575889 |
| 115 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.48689955 |
| 116 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.46912668 |
| 117 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.44737342 |
| 118 | heme transport (GO:0015886) | 3.44415220 |
| 119 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.40764470 |
| 120 | tetrahydrofolate metabolic process (GO:0046653) | 3.34798404 |
| 121 | negative regulation of coagulation (GO:0050819) | 3.29235461 |
| 122 | desmosome organization (GO:0002934) | 3.24874587 |
| 123 | primary alcohol metabolic process (GO:0034308) | 3.18935053 |
| 124 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 3.17944511 |
| 125 | negative regulation of wound healing (GO:0061045) | 3.12862447 |
| 126 | lipoprotein transport (GO:0042953) | 3.11949858 |
| 127 | L-ascorbic acid metabolic process (GO:0019852) | 3.08305313 |
| 128 | diacylglycerol metabolic process (GO:0046339) | 3.06945521 |
| 129 | regulation of cell-cell adhesion mediated by cadherin (GO:2000047) | 3.04237824 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.17783679 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.09898719 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.90352316 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.31847076 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.28865125 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.27247529 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.50528620 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.06188667 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.83227048 |
| 10 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.59671123 |
| 11 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.45976635 |
| 12 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 2.31978640 |
| 13 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.29527153 |
| 14 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.16533289 |
| 15 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.06295514 |
| 16 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.01148683 |
| 17 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.7750845 |
| 18 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.98225221 |
| 19 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.95995986 |
| 20 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.95415406 |
| 21 | GATA1_22025678_ChIP-Seq_K562_Human | 1.84491164 |
| 22 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.59580006 |
| 23 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.58685067 |
| 24 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.58685067 |
| 25 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.58685067 |
| 26 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.58490221 |
| 27 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.50567568 |
| 28 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.49610078 |
| 29 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.47567016 |
| 30 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.45170986 |
| 31 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.43582256 |
| 32 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.41244765 |
| 33 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.39061808 |
| 34 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.36174904 |
| 35 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.36078853 |
| 36 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.34262482 |
| 37 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.33912435 |
| 38 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.33748237 |
| 39 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.29476501 |
| 40 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.23473857 |
| 41 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.21887287 |
| 42 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.20257964 |
| 43 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.19787620 |
| 44 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.17724744 |
| 45 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.13296817 |
| 46 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.12925771 |
| 47 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.12737248 |
| 48 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.11482599 |
| 49 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.11273935 |
| 50 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.10430229 |
| 51 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.08200927 |
| 52 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.03568838 |
| 53 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.02376038 |
| 54 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.01123971 |
| 55 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.01019050 |
| 56 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.98626950 |
| 57 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.94550295 |
| 58 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 0.91955996 |
| 59 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.91096231 |
| 60 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.89278799 |
| 61 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.89152711 |
| 62 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.89008105 |
| 63 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.87434236 |
| 64 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.87002813 |
| 65 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.86943245 |
| 66 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.85063809 |
| 67 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.85018824 |
| 68 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.84960528 |
| 69 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.84792255 |
| 70 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.84334176 |
| 71 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.82806195 |
| 72 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.82560614 |
| 73 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 0.81765919 |
| 74 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.81618064 |
| 75 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.81598189 |
| 76 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.79766208 |
| 77 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.79736723 |
| 78 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.79156472 |
| 79 | P68_20966046_ChIP-Seq_HELA_Human | 0.77752078 |
| 80 | * SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.76150342 |
| 81 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.76008228 |
| 82 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.75847266 |
| 83 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.75838680 |
| 84 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.75686787 |
| 85 | POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 0.75372245 |
| 86 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.74965936 |
| 87 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.74645541 |
| 88 | KAP1_27257070_Chip-Seq_ESCs_Mouse | 0.74561191 |
| 89 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.74350277 |
| 90 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.74292372 |
| 91 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.74245382 |
| 92 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.73929182 |
| 93 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.73913546 |
| 94 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.72674802 |
| 95 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.71720766 |
| 96 | AR_20517297_ChIP-Seq_VCAP_Human | 0.71483596 |
| 97 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.70790848 |
| 98 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.70387863 |
| 99 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.70296642 |
| 100 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.70221541 |
| 101 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.70007867 |
| 102 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.69902024 |
| 103 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.68977820 |
| 104 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.67842092 |
| 105 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.67600539 |
| 106 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.67464435 |
| 107 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.66597858 |
| 108 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.66154053 |
| 109 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.65575620 |
| 110 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.65098162 |
| 111 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.64835489 |
| 112 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.64789844 |
| 113 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.62515412 |
| 114 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.61050329 |
| 115 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.60600328 |
| 116 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.59760050 |
| 117 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.59390970 |
| 118 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.56968905 |
| 119 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.55782324 |
| 120 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.55650516 |
| 121 | * CEBPB_22108803_ChIP-Seq_LS180_Human | 0.55307887 |
| 122 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.54665662 |
| 123 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.54543865 |
| 124 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.53199295 |
| 125 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.52317030 |
| 126 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.52106597 |
| 127 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.50612676 |
| 128 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.50612676 |
| 129 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.50202502 |
| 130 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.49484800 |
| 131 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.49410386 |
| 132 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.48858764 |
| 133 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.48442750 |
| 134 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.48071182 |
| 135 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.46994456 |
| 136 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.46242474 |
| 137 | CBP_21632823_ChIP-Seq_H3396_Human | 0.45026953 |
| 138 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.44876946 |
| 139 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.44339190 |
| 140 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.44236001 |
| 141 | GATA1_19941826_ChIP-Seq_K562_Human | 0.42941497 |
| 142 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.40726631 |
| 143 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.40455858 |
| 144 | GATA2_19941826_ChIP-Seq_K562_Human | 0.40189829 |
| 145 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.38598772 |
| 146 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.38101185 |
| 147 | * SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.37364970 |
| 148 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.36654790 |
| 149 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.36552346 |
| 150 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.36541751 |
| 151 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.36021291 |
| 152 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.35665110 |
| 153 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.35655387 |
| 154 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.35074945 |
| 155 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.34751221 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.86870741 |
| 2 | MP0005360_urolithiasis | 7.17966918 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.42492599 |
| 4 | MP0005365_abnormal_bile_salt | 6.34230143 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.67023092 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.15885253 |
| 7 | MP0003252_abnormal_bile_duct | 3.86100175 |
| 8 | MP0005083_abnormal_biliary_tract | 3.45969926 |
| 9 | MP0010329_abnormal_lipoprotein_level | 3.45841797 |
| 10 | MP0001666_abnormal_nutrient_absorption | 3.26618131 |
| 11 | MP0009840_abnormal_foam_cell | 3.02483056 |
| 12 | MP0003195_calcinosis | 2.87065712 |
| 13 | MP0005332_abnormal_amino_acid | 2.67677481 |
| 14 | MP0003868_abnormal_feces_composition | 2.55608557 |
| 15 | MP0000566_synostosis | 2.41432997 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 2.36499051 |
| 17 | MP0002138_abnormal_hepatobiliary_system | 2.20611287 |
| 18 | MP0004019_abnormal_vitamin_homeostasis | 2.17210984 |
| 19 | MP0000609_abnormal_liver_physiology | 2.11976180 |
| 20 | MP0002118_abnormal_lipid_homeostasis | 2.08599736 |
| 21 | MP0003183_abnormal_peptide_metabolism | 1.89736972 |
| 22 | MP0003941_abnormal_skin_development | 1.76284798 |
| 23 | MP0005319_abnormal_enzyme/_coenzyme | 1.76111905 |
| 24 | MP0001764_abnormal_homeostasis | 1.73855222 |
| 25 | MP0009697_abnormal_copulation | 1.55369814 |
| 26 | MP0002089_abnormal_postnatal_growth/wei | 1.53233597 |
| 27 | MP0005220_abnormal_exocrine_pancreas | 1.45650722 |
| 28 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.42071481 |
| 29 | MP0009643_abnormal_urine_homeostasis | 1.36212552 |
| 30 | MP0003011_delayed_dark_adaptation | 1.32965112 |
| 31 | MP0005084_abnormal_gallbladder_morpholo | 1.32111977 |
| 32 | MP0003186_abnormal_redox_activity | 1.30814968 |
| 33 | MP0003693_abnormal_embryo_hatching | 1.26876064 |
| 34 | MP0005451_abnormal_body_composition | 1.26277393 |
| 35 | MP0003656_abnormal_erythrocyte_physiolo | 1.26016672 |
| 36 | MP0004147_increased_porphyrin_level | 1.23637453 |
| 37 | MP0004185_abnormal_adipocyte_glucose | 1.20188413 |
| 38 | MP0000678_abnormal_parathyroid_gland | 1.17704490 |
| 39 | MP0000598_abnormal_liver_morphology | 1.17683492 |
| 40 | MP0002938_white_spotting | 1.13901835 |
| 41 | MP0005636_abnormal_mineral_homeostasis | 1.07465504 |
| 42 | MP0003890_abnormal_embryonic-extraembry | 1.03665016 |
| 43 | MP0004957_abnormal_blastocyst_morpholog | 1.02780704 |
| 44 | MP0000462_abnormal_digestive_system | 0.98799644 |
| 45 | MP0003283_abnormal_digestive_organ | 0.98548337 |
| 46 | MP0003122_maternal_imprinting | 0.98089887 |
| 47 | MP0005647_abnormal_sex_gland | 0.97561411 |
| 48 | MP0009763_increased_sensitivity_to | 0.96416835 |
| 49 | MP0003705_abnormal_hypodermis_morpholog | 0.95989769 |
| 50 | MP0003567_abnormal_fetal_cardiomyocyte | 0.95773400 |
| 51 | MP0002078_abnormal_glucose_homeostasis | 0.95465745 |
| 52 | MP0009764_decreased_sensitivity_to | 0.94827844 |
| 53 | MP0004133_heterotaxia | 0.93213508 |
| 54 | MP0008469_abnormal_protein_level | 0.91459978 |
| 55 | MP0009642_abnormal_blood_homeostasis | 0.91063565 |
| 56 | MP0005646_abnormal_pituitary_gland | 0.89913624 |
| 57 | MP0002254_reproductive_system_inflammat | 0.87613363 |
| 58 | MP0005408_hypopigmentation | 0.87364924 |
| 59 | MP0005670_abnormal_white_adipose | 0.87229058 |
| 60 | MP0010368_abnormal_lymphatic_system | 0.86007243 |
| 61 | MP0002876_abnormal_thyroid_physiology | 0.85883750 |
| 62 | MP0000013_abnormal_adipose_tissue | 0.85792969 |
| 63 | MP0006036_abnormal_mitochondrial_physio | 0.85197540 |
| 64 | MP0003123_paternal_imprinting | 0.84309293 |
| 65 | MP0000477_abnormal_intestine_morphology | 0.82763435 |
| 66 | MP0004264_abnormal_extraembryonic_tissu | 0.82533182 |
| 67 | MP0000490_abnormal_crypts_of | 0.82449437 |
| 68 | MP0009765_abnormal_xenobiotic_induced | 0.79653978 |
| 69 | MP0003119_abnormal_digestive_system | 0.77893348 |
| 70 | MP0005376_homeostasis/metabolism_phenot | 0.75953761 |
| 71 | MP0001730_embryonic_growth_arrest | 0.75197179 |
| 72 | MP0010352_gastrointestinal_tract_polyps | 0.73726345 |
| 73 | MP0000604_amyloidosis | 0.73608042 |
| 74 | MP0005334_abnormal_fat_pad | 0.72369073 |
| 75 | MP0005448_abnormal_energy_balance | 0.68532354 |
| 76 | MP0002697_abnormal_eye_size | 0.68431051 |
| 77 | MP0003315_abnormal_perineum_morphology | 0.67746702 |
| 78 | MP0001664_abnormal_digestion | 0.67320305 |
| 79 | MP0001756_abnormal_urination | 0.67114319 |
| 80 | MP0002249_abnormal_larynx_morphology | 0.67076090 |
| 81 | MP0001944_abnormal_pancreas_morphology | 0.66841554 |
| 82 | MP0002928_abnormal_bile_duct | 0.65419647 |
| 83 | MP0005535_abnormal_body_temperature | 0.64482470 |
| 84 | MP0002971_abnormal_brown_adipose | 0.64366636 |
| 85 | MP0005381_digestive/alimentary_phenotyp | 0.64323341 |
| 86 | MP0003111_abnormal_nucleus_morphology | 0.63508501 |
| 87 | MP0000003_abnormal_adipose_tissue | 0.62470395 |
| 88 | MP0009379_abnormal_foot_pigmentation | 0.61717377 |
| 89 | MP0005266_abnormal_metabolism | 0.61303946 |
| 90 | MP0000639_abnormal_adrenal_gland | 0.57325107 |
| 91 | MP0002693_abnormal_pancreas_physiology | 0.56244104 |
| 92 | MP0003953_abnormal_hormone_level | 0.55490114 |
| 93 | MP0001661_extended_life_span | 0.54549706 |
| 94 | MP0005464_abnormal_platelet_physiology | 0.50008682 |
| 95 | MP0004043_abnormal_pH_regulation | 0.49766269 |
| 96 | MP0005377_hearing/vestibular/ear_phenot | 0.49513355 |
| 97 | MP0003878_abnormal_ear_physiology | 0.49513355 |
| 98 | MP0003638_abnormal_response/metabolism_ | 0.49390911 |
| 99 | MP0006035_abnormal_mitochondrial_morpho | 0.49081296 |
| 100 | MP0001915_intracranial_hemorrhage | 0.48784711 |
| 101 | MP0009053_abnormal_anal_canal | 0.46964661 |
| 102 | MP0010155_abnormal_intestine_physiology | 0.46348746 |
| 103 | MP0002136_abnormal_kidney_physiology | 0.46063628 |
| 104 | MP0002233_abnormal_nose_morphology | 0.45931610 |
| 105 | MP0010234_abnormal_vibrissa_follicle | 0.45395641 |
| 106 | MP0004130_abnormal_muscle_cell | 0.44355475 |
| 107 | MP0005367_renal/urinary_system_phenotyp | 0.44221902 |
| 108 | MP0000516_abnormal_urinary_system | 0.44221902 |
| 109 | MP0009384_cardiac_valve_regurgitation | 0.44139558 |
| 110 | MP0002086_abnormal_extraembryonic_tissu | 0.42965812 |
| 111 | MP0001849_ear_inflammation | 0.42844126 |
| 112 | MP0003436_decreased_susceptibility_to | 0.42304565 |
| 113 | MP0003937_abnormal_limbs/digits/tail_de | 0.42144312 |
| 114 | MP0004782_abnormal_surfactant_physiolog | 0.42089480 |
| 115 | MP0003724_increased_susceptibility_to | 0.41568056 |
| 116 | MP0003959_abnormal_lean_body | 0.41338574 |
| 117 | MP0002909_abnormal_adrenal_gland | 0.40585877 |
| 118 | MP0002111_abnormal_tail_morphology | 0.40148410 |
| 119 | MP0005395_other_phenotype | 0.39962818 |
| 120 | MP0002837_dystrophic_cardiac_calcinosis | 0.39770790 |
| 121 | MP0003718_maternal_effect | 0.39490065 |
| 122 | MP0005666_abnormal_adipose_tissue | 0.38704437 |
| 123 | MP0000579_abnormal_nail_morphology | 0.38012359 |
| 124 | MP0001845_abnormal_inflammatory_respons | 0.37682787 |
| 125 | MP0008873_increased_physiological_sensi | 0.37443529 |
| 126 | MP0005166_decreased_susceptibility_to | 0.36158103 |
| 127 | MP0003300_gastrointestinal_ulcer | 0.34987353 |
| 128 | MP0002796_impaired_skin_barrier | 0.34307096 |
| 129 | MP0002132_abnormal_respiratory_system | 0.34178015 |
| 130 | MP0002060_abnormal_skin_morphology | 0.33539058 |
| 131 | MP0008004_abnormal_stomach_pH | 0.32579734 |
| 132 | MP0002970_abnormal_white_adipose | 0.32151937 |
| 133 | MP0009672_abnormal_birth_weight | 0.31997491 |
| 134 | MP0000230_abnormal_systemic_arterial | 0.31926480 |
| 135 | MP0005248_abnormal_Harderian_gland | 0.31867314 |
| 136 | MP0003690_abnormal_glial_cell | 0.31544979 |
| 137 | MP0001765_abnormal_ion_homeostasis | 0.30475664 |
| 138 | MP0004381_abnormal_hair_follicle | 0.30109354 |
| 139 | MP0002822_catalepsy | 0.29917295 |
| 140 | MP0001243_abnormal_dermal_layer | 0.28922089 |
| 141 | MP0001663_abnormal_digestive_system | 0.27831244 |
| 142 | MP0008872_abnormal_physiological_respon | 0.27716618 |
| 143 | MP0001873_stomach_inflammation | 0.27571865 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.50107353 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 7.14742548 |
| 3 | Deep venous thrombosis (HP:0002625) | 6.83943873 |
| 4 | Prolonged partial thromboplastin time (HP:0003645) | 6.49762305 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.45160554 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 6.05290940 |
| 7 | Xanthomatosis (HP:0000991) | 5.97413114 |
| 8 | Complement deficiency (HP:0004431) | 5.27327817 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 5.18514750 |
| 10 | Abnormality of the common coagulation pathway (HP:0010990) | 4.66035185 |
| 11 | Joint hemorrhage (HP:0005261) | 4.60957696 |
| 12 | Hypolipoproteinemia (HP:0010981) | 4.58789606 |
| 13 | Hypoglycemic coma (HP:0001325) | 4.45052155 |
| 14 | Hyperammonemia (HP:0001987) | 4.41762308 |
| 15 | Fat malabsorption (HP:0002630) | 4.36117329 |
| 16 | Ketosis (HP:0001946) | 4.34540865 |
| 17 | Hyperglycinemia (HP:0002154) | 4.31739938 |
| 18 | Abnormality of the intrinsic pathway (HP:0010989) | 4.22561699 |
| 19 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.19837502 |
| 20 | Epidermoid cyst (HP:0200040) | 4.17638033 |
| 21 | Abnormality of methionine metabolism (HP:0010901) | 4.15195018 |
| 22 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.11808851 |
| 23 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.07829696 |
| 24 | Hypoalphalipoproteinemia (HP:0003233) | 4.02982155 |
| 25 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.99211088 |
| 26 | Conjugated hyperbilirubinemia (HP:0002908) | 3.93920941 |
| 27 | Abnormality of complement system (HP:0005339) | 3.88255743 |
| 28 | Hyperglycinuria (HP:0003108) | 3.74837088 |
| 29 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 3.71707908 |
| 30 | Abnormality of alanine metabolism (HP:0010916) | 3.71707908 |
| 31 | Hyperalaninemia (HP:0003348) | 3.71707908 |
| 32 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.67977920 |
| 33 | Abnormality of glycine metabolism (HP:0010895) | 3.67977920 |
| 34 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.55245001 |
| 35 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.45929153 |
| 36 | Steatorrhea (HP:0002570) | 3.31154528 |
| 37 | Hypercholesterolemia (HP:0003124) | 3.29297660 |
| 38 | Hypoglycemic seizures (HP:0002173) | 3.28769602 |
| 39 | Hyperbilirubinemia (HP:0002904) | 3.28104753 |
| 40 | Ketoacidosis (HP:0001993) | 3.26654372 |
| 41 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.26001002 |
| 42 | Spontaneous abortion (HP:0005268) | 3.10092924 |
| 43 | Abnormality of nucleobase metabolism (HP:0010932) | 3.03723213 |
| 44 | Abnormality of serum amino acid levels (HP:0003112) | 2.96763223 |
| 45 | Megaloblastic anemia (HP:0001889) | 2.93489228 |
| 46 | Hepatocellular carcinoma (HP:0001402) | 2.84132328 |
| 47 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.80150551 |
| 48 | Gout (HP:0001997) | 2.78588978 |
| 49 | Abnormality of purine metabolism (HP:0004352) | 2.77962319 |
| 50 | Delayed CNS myelination (HP:0002188) | 2.76875680 |
| 51 | Metabolic acidosis (HP:0001942) | 2.75661220 |
| 52 | Hemorrhage of the eye (HP:0011885) | 2.75060151 |
| 53 | Ileus (HP:0002595) | 2.73836488 |
| 54 | Lethargy (HP:0001254) | 2.65986315 |
| 55 | Dicarboxylic aciduria (HP:0003215) | 2.64390930 |
| 56 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.64390930 |
| 57 | Myocardial infarction (HP:0001658) | 2.64370706 |
| 58 | Late onset (HP:0003584) | 2.63014774 |
| 59 | Abnormality of carpal bone ossification (HP:0006257) | 2.62886954 |
| 60 | Skin nodule (HP:0200036) | 2.60231789 |
| 61 | Flat acetabular roof (HP:0003180) | 2.59447630 |
| 62 | Abnormality of homocysteine metabolism (HP:0010919) | 2.58149530 |
| 63 | Homocystinuria (HP:0002156) | 2.58149530 |
| 64 | Acanthocytosis (HP:0001927) | 2.57878934 |
| 65 | Hypochromic microcytic anemia (HP:0004840) | 2.56401608 |
| 66 | Systemic lupus erythematosus (HP:0002725) | 2.54751951 |
| 67 | Hyperphosphaturia (HP:0003109) | 2.53931607 |
| 68 | Symptomatic seizures (HP:0011145) | 2.48752363 |
| 69 | Proximal tubulopathy (HP:0000114) | 2.46362123 |
| 70 | Vascular calcification (HP:0004934) | 2.44809768 |
| 71 | Glycosuria (HP:0003076) | 2.44669739 |
| 72 | Abnormality of urine glucose concentration (HP:0011016) | 2.44669739 |
| 73 | Cerebral edema (HP:0002181) | 2.43234873 |
| 74 | Hyperuricemia (HP:0002149) | 2.41794858 |
| 75 | Generalized aminoaciduria (HP:0002909) | 2.37641863 |
| 76 | Irritability (HP:0000737) | 2.36557966 |
| 77 | Increased serum pyruvate (HP:0003542) | 2.35784550 |
| 78 | Pancreatitis (HP:0001733) | 2.34915414 |
| 79 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.30755718 |
| 80 | Abnormal gallbladder morphology (HP:0012437) | 2.30375313 |
| 81 | Gingival bleeding (HP:0000225) | 2.30113369 |
| 82 | Enlarged kidneys (HP:0000105) | 2.28879446 |
| 83 | Amyloidosis (HP:0011034) | 2.26959087 |
| 84 | Hyperglycemia (HP:0003074) | 2.25227039 |
| 85 | Malnutrition (HP:0004395) | 2.24493912 |
| 86 | Congenital sensorineural hearing impairment (HP:0008527) | 2.24356872 |
| 87 | Glomerulonephritis (HP:0000099) | 2.23012579 |
| 88 | Menorrhagia (HP:0000132) | 2.19900863 |
| 89 | Widely patent fontanelles and sutures (HP:0004492) | 2.19823177 |
| 90 | Pigmentary retinal degeneration (HP:0001146) | 2.18316817 |
| 91 | Cholelithiasis (HP:0001081) | 2.18112278 |
| 92 | Osteomalacia (HP:0002749) | 2.17065425 |
| 93 | Esophageal varix (HP:0002040) | 2.13941181 |
| 94 | Abnormal urine phosphate concentration (HP:0012599) | 2.12440871 |
| 95 | Cardiovascular calcification (HP:0011915) | 2.12016208 |
| 96 | Abnormality of glycolysis (HP:0004366) | 2.11974351 |
| 97 | Cholecystitis (HP:0001082) | 2.10316970 |
| 98 | Abnormal gallbladder physiology (HP:0012438) | 2.10316970 |
| 99 | Neonatal onset (HP:0003623) | 2.08398133 |
| 100 | Brushfield spots (HP:0001088) | 2.08377739 |
| 101 | Abnormality of alkaline phosphatase activity (HP:0004379) | 2.07850154 |
| 102 | Pulmonary embolism (HP:0002204) | 2.07727896 |
| 103 | Spastic diplegia (HP:0001264) | 2.06945718 |
| 104 | Vaginal fistula (HP:0004320) | 2.05299785 |
| 105 | Abnormal tarsal ossification (HP:0008369) | 2.04920764 |
| 106 | Mitral stenosis (HP:0001718) | 2.04811823 |
| 107 | Nephritis (HP:0000123) | 2.03827799 |
| 108 | Vomiting (HP:0002013) | 2.03506521 |
| 109 | Thrombophlebitis (HP:0004418) | 2.01408311 |
| 110 | Anorexia (HP:0002039) | 1.99022213 |
| 111 | Abnormal umbilical cord blood vessels (HP:0011403) | 1.98953689 |
| 112 | Single umbilical artery (HP:0001195) | 1.98953689 |
| 113 | Abnormality of the fetal cardiovascular system (HP:0010948) | 1.98953689 |
| 114 | Sensorimotor neuropathy (HP:0007141) | 1.98387344 |
| 115 | Hypophosphatemic rickets (HP:0004912) | 1.96617559 |
| 116 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.96354261 |
| 117 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.96354261 |
| 118 | Opisthotonus (HP:0002179) | 1.96213197 |
| 119 | Rickets (HP:0002748) | 1.94336009 |
| 120 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.92900329 |
| 121 | Prenatal maternal abnormality (HP:0002686) | 1.92753393 |
| 122 | Renal cortical cysts (HP:0000803) | 1.92721437 |
| 123 | Nausea (HP:0002018) | 1.92020400 |
| 124 | Abnormality of vitamin metabolism (HP:0100508) | 1.91451935 |
| 125 | Protuberant abdomen (HP:0001538) | 1.90701251 |
| 126 | Elevated alkaline phosphatase (HP:0003155) | 1.90195951 |
| 127 | Abnormal cartilage morphology (HP:0002763) | 1.89751758 |
| 128 | Abnormality of the gallbladder (HP:0005264) | 1.88936751 |
| 129 | Hemangiomatosis (HP:0007461) | 1.88900137 |
| 130 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.88299838 |
| 131 | Visceral angiomatosis (HP:0100761) | 1.88169776 |
| 132 | Abnormality of vitamin B metabolism (HP:0004340) | 1.87883866 |
| 133 | Elevated hepatic transaminases (HP:0002910) | 1.87437028 |
| 134 | Hydroxyprolinuria (HP:0003080) | 1.86942640 |
| 135 | Abnormality of proline metabolism (HP:0010907) | 1.86942640 |
| 136 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.86644722 |
| 137 | Poikilocytosis (HP:0004447) | 1.86449625 |
| 138 | Reduced antithrombin III activity (HP:0001976) | 1.86114600 |
| 139 | Abnormal hand bone ossification (HP:0010660) | 1.86105600 |
| 140 | Increased purine levels (HP:0004368) | 1.84852343 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.01068232 |
| 2 | ERN1 | 4.75517432 |
| 3 | INSRR | 4.16943954 |
| 4 | FGFR4 | 4.03680427 |
| 5 | ACVR1B | 3.67992222 |
| 6 | SIK1 | 3.54550601 |
| 7 | TAOK3 | 3.35630269 |
| 8 | SMG1 | 3.17629904 |
| 9 | ERBB4 | 3.16677531 |
| 10 | LMTK2 | 3.09488734 |
| 11 | FRK | 3.00564643 |
| 12 | NEK1 | 2.41809331 |
| 13 | MST1R | 2.33948088 |
| 14 | FLT3 | 2.27129297 |
| 15 | VRK2 | 2.07709330 |
| 16 | TTK | 1.97859990 |
| 17 | MAPK15 | 1.93662557 |
| 18 | PKN2 | 1.89202438 |
| 19 | MAPK11 | 1.85501311 |
| 20 | NME1 | 1.81360240 |
| 21 | FGR | 1.81126759 |
| 22 | PIK3CG | 1.80585844 |
| 23 | CDK9 | 1.79176821 |
| 24 | RPS6KB2 | 1.76920265 |
| 25 | MAP3K3 | 1.62224565 |
| 26 | PTK6 | 1.60321276 |
| 27 | TRIB3 | 1.56576120 |
| 28 | IRAK3 | 1.54464778 |
| 29 | CDC7 | 1.53922611 |
| 30 | STK38L | 1.52199008 |
| 31 | MAP2K4 | 1.50265503 |
| 32 | MST4 | 1.50178821 |
| 33 | TAF1 | 1.43310429 |
| 34 | FGFR1 | 1.42775104 |
| 35 | LATS1 | 1.39417867 |
| 36 | ICK | 1.39204448 |
| 37 | EEF2K | 1.27847764 |
| 38 | STK16 | 1.26804087 |
| 39 | EPHA3 | 1.25932268 |
| 40 | SGK494 | 1.23910492 |
| 41 | SGK223 | 1.23910492 |
| 42 | NEK9 | 1.23346581 |
| 43 | CDK12 | 1.22512674 |
| 44 | TYK2 | 1.18889577 |
| 45 | PAK4 | 1.18684999 |
| 46 | MAP3K11 | 1.13189929 |
| 47 | BUB1 | 1.10639017 |
| 48 | MAP2K2 | 1.09193906 |
| 49 | CDK7 | 1.08644275 |
| 50 | BRSK2 | 1.05780578 |
| 51 | WNK4 | 1.05405864 |
| 52 | PRKAA2 | 1.03538070 |
| 53 | JAK2 | 1.02441176 |
| 54 | TYRO3 | 1.00919888 |
| 55 | ABL2 | 1.00511983 |
| 56 | ERBB2 | 0.99825809 |
| 57 | MET | 0.96103252 |
| 58 | STK24 | 0.95462763 |
| 59 | DYRK2 | 0.94834785 |
| 60 | TBK1 | 0.93440945 |
| 61 | TNIK | 0.91468113 |
| 62 | MAP3K14 | 0.89835014 |
| 63 | MAP2K6 | 0.89822345 |
| 64 | DYRK1B | 0.88662584 |
| 65 | DAPK2 | 0.87096573 |
| 66 | MAP3K7 | 0.83331062 |
| 67 | KDR | 0.82947758 |
| 68 | JAK1 | 0.79600644 |
| 69 | GRK6 | 0.77909487 |
| 70 | EPHB1 | 0.77465318 |
| 71 | PINK1 | 0.73954968 |
| 72 | PRKCI | 0.73945805 |
| 73 | NLK | 0.72902124 |
| 74 | BMX | 0.72809748 |
| 75 | EPHB2 | 0.72668696 |
| 76 | NUAK1 | 0.72302170 |
| 77 | MAP2K3 | 0.70373573 |
| 78 | PLK4 | 0.70013970 |
| 79 | PRKG2 | 0.69919425 |
| 80 | FGFR2 | 0.69725647 |
| 81 | MAPK4 | 0.69649610 |
| 82 | GRK1 | 0.68228927 |
| 83 | CSNK1E | 0.67722950 |
| 84 | TSSK6 | 0.66192202 |
| 85 | PRKAA1 | 0.65929129 |
| 86 | STK39 | 0.65812534 |
| 87 | EPHA2 | 0.65685525 |
| 88 | CAMK2G | 0.64431138 |
| 89 | RIPK1 | 0.63631727 |
| 90 | GSK3A | 0.63213831 |
| 91 | PRKACG | 0.63090684 |
| 92 | PRKCZ | 0.62570775 |
| 93 | PTK2 | 0.62260436 |
| 94 | PLK3 | 0.61538811 |
| 95 | BRSK1 | 0.60085030 |
| 96 | MAP3K1 | 0.59010377 |
| 97 | MAP3K2 | 0.58685002 |
| 98 | CSNK1A1 | 0.58298672 |
| 99 | CHEK2 | 0.58205030 |
| 100 | IRAK1 | 0.57060768 |
| 101 | MAP3K10 | 0.55951250 |
| 102 | MAP3K8 | 0.55940930 |
| 103 | OXSR1 | 0.55617026 |
| 104 | TIE1 | 0.55571871 |
| 105 | SGK2 | 0.55168913 |
| 106 | CSK | 0.55157243 |
| 107 | MAP2K1 | 0.54953714 |
| 108 | TGFBR2 | 0.54155791 |
| 109 | CSNK2A1 | 0.53921754 |
| 110 | FGFR3 | 0.53063814 |
| 111 | CSNK2A2 | 0.51521871 |
| 112 | STK4 | 0.51242893 |
| 113 | STK3 | 0.51029685 |
| 114 | PDGFRA | 0.50834988 |
| 115 | PIK3CA | 0.50750594 |
| 116 | MATK | 0.49546656 |
| 117 | PLK1 | 0.48695466 |
| 118 | NEK2 | 0.48373883 |
| 119 | SRPK1 | 0.44928051 |
| 120 | ALK | 0.44469008 |
| 121 | MAPK12 | 0.44407923 |
| 122 | SGK1 | 0.42266098 |
| 123 | EIF2AK3 | 0.41422295 |
| 124 | IKBKE | 0.40588408 |
| 125 | BRD4 | 0.40335372 |
| 126 | WNK3 | 0.39679420 |
| 127 | ZAK | 0.39520768 |
| 128 | CDK6 | 0.39081602 |
| 129 | AKT2 | 0.38994033 |
| 130 | PDK2 | 0.38574895 |
| 131 | NTRK3 | 0.37733153 |
| 132 | AURKA | 0.37403147 |
| 133 | IGF1R | 0.36973878 |
| 134 | PDPK1 | 0.36262098 |
| 135 | MAPK7 | 0.35429734 |
| 136 | SGK3 | 0.31596423 |
| 137 | PRKCQ | 0.31030823 |
| 138 | CSNK1G1 | 0.30694379 |
| 139 | CAMK1D | 0.30503772 |
| 140 | PBK | 0.29864339 |
| 141 | PASK | 0.28622708 |
| 142 | MTOR | 0.26844921 |
| 143 | MAP3K5 | 0.26257565 |
| 144 | CHUK | 0.25401733 |
| 145 | NME2 | 0.24865852 |
| 146 | CDK4 | 0.23854442 |
| 147 | PRKCA | 0.23052483 |
| 148 | ZAP70 | 0.22985753 |
| 149 | MAPK3 | 0.22894207 |
| 150 | RET | 0.22589541 |
| 151 | JAK3 | 0.22273083 |
| 152 | AKT3 | 0.21829424 |
| 153 | CSF1R | 0.20294550 |
| 154 | PDK1 | 0.19795541 |
| 155 | PRKCG | 0.16503954 |
| 156 | TGFBR1 | 0.16077794 |
| 157 | FER | 0.15716418 |
| 158 | EGFR | 0.15349525 |
| 159 | RPS6KB1 | 0.15288740 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.45531157 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.46473751 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.24954340 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.17925806 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.98325704 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.76368145 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.69211166 |
| 8 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.58789538 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.53885149 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.44106336 |
| 11 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.42539044 |
| 12 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.37894159 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.18272613 |
| 14 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.06032166 |
| 15 | Peroxisome_Homo sapiens_hsa04146 | 2.05757953 |
| 16 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.02391613 |
| 17 | Histidine metabolism_Homo sapiens_hsa00340 | 1.94674810 |
| 18 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.86384729 |
| 19 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.86206980 |
| 20 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.84686142 |
| 21 | * Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.83113963 |
| 22 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.80702645 |
| 23 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.77346065 |
| 24 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.75162360 |
| 25 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.74787987 |
| 26 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.70321054 |
| 27 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.68019005 |
| 28 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.65296554 |
| 29 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.63813542 |
| 30 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.63770093 |
| 31 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.62238939 |
| 32 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.61691920 |
| 33 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.59742739 |
| 34 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.59575607 |
| 35 | Retinol metabolism_Homo sapiens_hsa00830 | 1.58455714 |
| 36 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.55835725 |
| 37 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.54260561 |
| 38 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.41674988 |
| 39 | Bile secretion_Homo sapiens_hsa04976 | 1.41614054 |
| 40 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.39760763 |
| 41 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.37334887 |
| 42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.36014925 |
| 43 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.31228475 |
| 44 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.29694106 |
| 45 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.24659477 |
| 46 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.21019689 |
| 47 | ABC transporters_Homo sapiens_hsa02010 | 1.17255670 |
| 48 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.16622513 |
| 49 | Carbon metabolism_Homo sapiens_hsa01200 | 1.06580362 |
| 50 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.06006095 |
| 51 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.05348144 |
| 52 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.05029972 |
| 53 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.04775235 |
| 54 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.99961133 |
| 55 | Sulfur relay system_Homo sapiens_hsa04122 | 0.97486620 |
| 56 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.92884327 |
| 57 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.91816405 |
| 58 | Mineral absorption_Homo sapiens_hsa04978 | 0.80180544 |
| 59 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.77712308 |
| 60 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.75579778 |
| 61 | Lysine degradation_Homo sapiens_hsa00310 | 0.75227333 |
| 62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.73682956 |
| 63 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.72099811 |
| 64 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.67477153 |
| 65 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.67434160 |
| 66 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.59518171 |
| 67 | Metabolic pathways_Homo sapiens_hsa01100 | 0.52542945 |
| 68 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.51883905 |
| 69 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.50468069 |
| 70 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.45148340 |
| 71 | Galactose metabolism_Homo sapiens_hsa00052 | 0.45006577 |
| 72 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.42165910 |
| 73 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.40420681 |
| 74 | Prion diseases_Homo sapiens_hsa05020 | 0.38595877 |
| 75 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.32397400 |
| 76 | Protein export_Homo sapiens_hsa03060 | 0.30021699 |
| 77 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.29735451 |
| 78 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.28159934 |
| 79 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.25459119 |
| 80 | Insulin resistance_Homo sapiens_hsa04931 | 0.24940668 |
| 81 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.19190580 |
| 82 | Proteasome_Homo sapiens_hsa03050 | 0.16966324 |
| 83 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.16749669 |
| 84 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.15554823 |
| 85 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.14156953 |
| 86 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.12019333 |
| 87 | Ribosome_Homo sapiens_hsa03010 | 0.11451921 |
| 88 | DNA replication_Homo sapiens_hsa03030 | 0.10734529 |
| 89 | Base excision repair_Homo sapiens_hsa03410 | 0.10723006 |
| 90 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.09723807 |
| 91 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.09027560 |
| 92 | Tight junction_Homo sapiens_hsa04530 | 0.08963346 |
| 93 | Spliceosome_Homo sapiens_hsa03040 | 0.07519379 |
| 94 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.06976031 |
| 95 | Thyroid cancer_Homo sapiens_hsa05216 | 0.06641472 |
| 96 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.06390519 |
| 97 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.05761869 |
| 98 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.00532022 |
| 99 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.00410405 |
| 100 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.1678492 |
| 101 | Other glycan degradation_Homo sapiens_hsa00511 | -0.1570273 |
| 102 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1475865 |
| 103 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.1466374 |
| 104 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1246284 |
| 105 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1243378 |
| 106 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1223801 |
| 107 | Hepatitis C_Homo sapiens_hsa05160 | -0.1159719 |
| 108 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1061293 |
| 109 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1011890 |
| 110 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0969825 |
| 111 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0922495 |
| 112 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0738262 |
| 113 | Pancreatic secretion_Homo sapiens_hsa04972 | -0.0151346 |
| 114 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0087604 |

